ClinicalTrials.govpublic full text
Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders
end stage renal disease, chronic kidney disease, sleep disorder, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 869426
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.